12 / 80
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 3, May/June 2017
146
AFRICA
dependent renal vasodilation mediated through nitric oxide and reac-
tive oxygen species scavenging.
Am J Physiol Renal Physiol
2014;
306
:
542–550.
26. Turan B, Tuncay E, Vassort G. Resveratrol and diabetic cardiac func-
tion: focus on recent in vitro and in vivo studies.
J Bioenerg Biomembr
2012;
44
: 281–296.
27. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric
oxide on peripheral arteriolar tone in man.
Lancet
1989;
2
: 997–1000.
28. Granger JP, Alexander BT. Abnormal pressure-natriuresis in hyperten-
sion: role of nitric oxide.
Acta Physiol Scand
2000;
168
: 161–168.
29. Johnson RA, Freeman RH. Pressure natriuresis in rats during blockade
of the L-arginine/nitric oxide pathway.
Hypertension
1992;
19
: 333–338.
30. Barrero MJ, Ojeda ML, Díaz Castro J, Nogales F, Murillo ML, Carreras
O. The effects of ethanol upon hydric balance and arterial pressure in
rats: folic acid as a possible hypotensor.
Life Sci
2012;
90
: 337–342.
31. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensi-
tivity to the pressor effect of salt.
Kidney Int
1994;
46
: 230–236.
32. Griffin K, Polichnowski A, Licea-Vargas H, Picken M, Long J,
Williamson G,
et al
. Large BP-dependent and -independent differences
in susceptibility to nephropathy after nitric oxide inhibition in Sprague-
Dawley rats from two major suppliers.
Am J Physiol Renal Physiol
2012;
302
: 173–182.
Dear Partner in RHD in Africa
9 May 2017
PASCAR Grant: Advocacy for RHD Eradication – Promoting the AU Communiqué
The Pan-African Society of Cardiology (PASCAR) has partnered with RHD Action and the World Heart Federation (WHF) to fund five projects (in five
different countries) to advance the “
African Union Communiqué on the Eradication of RHD in Africa
”. This is a competition for a policy dialogue on
the AU Communiqué on National Programmes for RHD.
We encourage proposals on your plans for a policy dialogue with policy makers in the Ministry of Health and related departments that will
introduce them to the AU Communiqué and lead to government supported national programmes and initiatives. In other words,
advocacy for action
.
The project, with clearly defined deliverables and outcomes, must be designed to achieve implementation of point 6 of the AU Communiqué namely,
an “
integrated, multidisciplinary, intersectoral national programme for the prevention and control of RHD
”.
The goal is increased government commitment to sustainable and comprehensive rheumatic heart disease (RHD) control.
The project should:
•
Involve a wide range of stakeholders such as government (Ministry of Health and other relevant ministries), non-governmental organizations,
community based organisations, professional associations, RHD champions, and people living with or affected by RHD.
•
Be aligned with regional/global initiatives for the prevention of RHD in Africa (e.g., Stop RHD A.S.A.P. Programme, RHD Action, World Heart Day).
•
Have clear, focused, measurable objectives which can be achieved over a period of 6 to 12 months.
Funding of US $2,000 per project is available for up to 5 successful applicants. The funding is payable in two tranches; firstly initiation of the project
and secondly on confirmation of deliverables. Deliverables for PASCAR are,
1. A narrative and financial report by latest end January 2018.
2. Meeting agendas, photographs, and press coverage of the activity, with as much human interest as possible as well as official government policy
statements in this regard.
Please see addendum below stipulating how to respond to this request for applications. We look forward to receiving innovative proposals that will
move the agenda of the AU Communiqué Programme forward in Africa.
With appreciation,
Professor Bongani M Mayosi
Dr Chris Hugo-Hamman
President, Pan-African Society of Cardiology
PASCAR RHD Task Force
Addendum on page 181